IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q4 2016 Holdings

Filed 2017-02-10 | 9 holdings | $199.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$78.4K3,835,83039.4%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$59.6K1,574,74929.9%
Alder Biopharmaceuticals Inc.(ALDR1EUR)COM014339105$20.7K995,39610.4%
Epizyme, Inc.(EPZMEUR)COM29428V104$18.5K1,526,6379.3%
NanoString Technologies, Inc.(NSTGEUR)COM63009R109$15.1K679,0337.6%
Nexvet Biopharma public limited companyORD SHSG6503X109$3.3K894,6951.7%
Zafgen, Inc.COM98885E103$2.1K663,7801.1%
Orexigen Therapeutics, Inc.COM686164302$944542,7550.5%
Acceleron Pharma Inc.(XLRN)COM00434H108$50819,9100.3%